Publication: Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: statement of Dermatoallergy Working Group of the Turkish Society of Dermatology
dc.contributor.coauthor | Salman, Andaç | |
dc.contributor.coauthor | Atakan, Nilgün | |
dc.contributor.coauthor | Başkan, Emel Bülbül | |
dc.contributor.coauthor | Borlu, Murat | |
dc.contributor.coauthor | Canpolat, Filiz | |
dc.contributor.coauthor | Erdem, Teoman | |
dc.contributor.coauthor | Erdem, Yasemin | |
dc.contributor.coauthor | Gül, Ülker | |
dc.contributor.coauthor | Kartal, Selda Pelin | |
dc.contributor.coauthor | Koca, Rafet | |
dc.contributor.coauthor | Küçük, Özlem Su | |
dc.contributor.coauthor | Öğretmen, Zerrin | |
dc.contributor.coauthor | Özkaya, Esen | |
dc.contributor.coauthor | Sarıcaoğlu, Hayriye | |
dc.contributor.coauthor | Savk, Ekin | |
dc.contributor.coauthor | Taşkapan, Oktay | |
dc.contributor.coauthor | Utas, Serap | |
dc.contributor.kuauthor | Alper, Fatma Sibel | |
dc.contributor.kuauthor | Kocatürk Göncü, Özgür Emek | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | 217219 | |
dc.date.accessioned | 2024-11-09T12:39:43Z | |
dc.date.issued | 2020 | |
dc.description.fulltext | YES | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.openaccess | YES | |
dc.description.publisherscope | National | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | N/A | |
dc.description.version | Publisher version | |
dc.format | ||
dc.identifier.doi | 10.4274/turkderm.galenos.2020.80000 | |
dc.identifier.eissn | 2651-5164 | |
dc.identifier.embargo | NO | |
dc.identifier.filenameinventoryno | IR02340 | |
dc.identifier.issn | 2717-6398 | |
dc.identifier.link | https://doi.org/10.4274/turkderm.galenos.2020.80000 | |
dc.identifier.quartile | N/A | |
dc.identifier.scopus | 2-s2.0-85089913448 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/2125 | |
dc.identifier.wos | 544409600008 | |
dc.keywords | Atopic dermatitis | |
dc.keywords | COVID-19 | |
dc.keywords | Dupilumab | |
dc.keywords | Omalizumab | |
dc.keywords | Treatment | |
dc.keywords | Urticaria | |
dc.language | English | |
dc.publisher | Galenos Yayınevi | |
dc.relation.grantno | NA | |
dc.relation.uri | http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/8972 | |
dc.source | Turkderm-Turkish Archives of Dermatology and Venereology / Türkderm-Türk Deri Hastalıkları ve Frengi Arşivi | |
dc.subject | Medicine | |
dc.subject | Dermatology | |
dc.title | Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: statement of Dermatoallergy Working Group of the Turkish Society of Dermatology | |
dc.type | Letter | |
dspace.entity.type | Publication | |
local.contributor.authorid | N/A | |
local.contributor.authorid | 0000-0003-2801-0959 | |
local.contributor.kuauthor | Alper, Fatma Sibel | |
local.contributor.kuauthor | Kocatürk Göncü, Özgür Emek |
Files
Original bundle
1 - 1 of 1